These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 12208228)

  • 21. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
    Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
    J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantable dual-chamber defibrillator for the selective treatment of spontaneous atrial and ventricular arrhythmias: arrhythmia incidence and device performance.
    Schuchert A; Boriani G; Wollmann C; Biffi M; Kühl M; Sperzel J; Stiller S; Gasparini G; Böcker D
    J Interv Card Electrophysiol; 2005 Mar; 12(2):149-56. PubMed ID: 15744468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced risk for inappropriate implantable cardioverter-defibrillator shocks with dual-chamber therapy compared with single-chamber therapy: results of the randomized OPTION study.
    Kolb C; Sturmer M; Sick P; Reif S; Davy JM; Molon G; Schwab JO; Mantovani G; Dan D; Lennerz C; Borri-Brunetto A; Babuty D
    JACC Heart Fail; 2014 Dec; 2(6):611-9. PubMed ID: 25282033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Combined anti-bradycardia/anti-tachycardia pacemaker-cardioverter-defibrillator systems in patients with recurrent ventricular tachyarrhythmias].
    Schmitt C; Brachmann J; Saggau W; Beyer T; Waldecker B; Scharowski K; Hilbel T; Montero M; Offner B; Schöls W
    Z Kardiol; 1991 Nov; 80(11):665-72. PubMed ID: 1792808
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effectiveness of rapid atrial pacing for termination of drug refractory atrial fibrillation: results of a dual chamber implantable cardioverter defibrillator trial.
    Gold MR; Leman RB; Euler DE
    Card Electrophysiol Rev; 2003 Dec; 7(4):341-4. PubMed ID: 15071249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Marked attenuation of shock burden by the use of antitachycardia pacing therapy in a patient with an implanted cardioverter-defibrillator.
    Ganjehei L; Nazeri A; Massumi A; Razavi M
    Tex Heart Inst J; 2012; 39(4):568-70. PubMed ID: 22949781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of inappropriate therapy in implantable cardioverter-defibrillators: results of a prospective, randomized study of tachyarrhythmia detection algorithms.
    Theuns DA; Klootwijk AP; Goedhart DM; Jordaens LJ
    J Am Coll Cardiol; 2004 Dec; 44(12):2362-7. PubMed ID: 15607399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transtelephonic monitoring and transmission of stored arrhythmia detection and therapy data from an implantable cardioverter defibrillator.
    Fetter JG; Stanton MS; Benditt DG; Trusty J; Collins J
    Pacing Clin Electrophysiol; 1995 Aug; 18(8):1531-9. PubMed ID: 7479174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical experience with a new cardioverter defibrillator capable of biphasic waveform pulse and enhanced data storage: results of a prospective multicenter study. European Ventak P2 Investigator Group.
    Neuzner J
    Pacing Clin Electrophysiol; 1994 Jul; 17(7):1243-55. PubMed ID: 7937230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low inappropriate shock rates in patients with single- and dual/triple-chamber implantable cardioverter-defibrillators using a novel suite of detection algorithms: PainFree SST trial primary results.
    Auricchio A; Schloss EJ; Kurita T; Meijer A; Gerritse B; Zweibel S; AlSmadi FM; Leng CT; Sterns LD;
    Heart Rhythm; 2015 May; 12(5):926-36. PubMed ID: 25637563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator.
    Gillis AM; Unterberg-Buchwald C; Schmidinger H; Massimo S; Wolfe K; Kavaney DJ; Otterness MF; Hohnloser SH;
    J Am Coll Cardiol; 2002 Nov; 40(9):1653-9. PubMed ID: 12427419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical impact of defibrillation testing at the time of implantable cardioverter-defibrillator insertion.
    Hadid C; Atienza F; Strasberg B; Arenal Á; Codner P; González-Torrecilla E; Datino T; Percal T; Almendral J; Ortiz M; Martins R; Martinez-Alzamora N; Fernandez Aviles F
    Cardiol J; 2015; 22(3):253-9. PubMed ID: 25179316
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of ventricular tachyarrhythmias with an implantable pacemaker-cardioverter-defibrillator].
    Ohm OJ; Faerestrand S; Engedal H; Hegbom F; Stangeland L; Hoff PI
    Tidsskr Nor Laegeforen; 1993 Jan; 113(2):182-9. PubMed ID: 8430397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low energy transvenous cardioversion of short duration atrial tachyarrhythmias in humans using a single lead system.
    Heisel A; Jung J; Fries R; Stopp M; Sen S; Schieffer H; Ozbek C
    Pacing Clin Electrophysiol; 1997 Jan; 20(1 Pt 1):65-71. PubMed ID: 9121973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial therapies reduce atrial arrhythmia burden in defibrillator patients.
    Friedman PA; Dijkman B; Warman EN; Xia HA; Mehra R; Stanton MS; Hammill SC
    Circulation; 2001 Aug; 104(9):1023-8. PubMed ID: 11524396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. First worldwide clinical experience with a new dual chamber implantable cardioverter defibrillator. Advantages and complications. The Ventak AV II DR investigators.
    Sticherling C; Schaumann A; Klingenheben T; Hohnloser SH
    Europace; 1999 Apr; 1(2):96-102. PubMed ID: 11233190
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SVT discrimination algorithms significantly reduce the rate of inappropriate therapy in the setting of modern-day delayed high-rate detection programming.
    Cheng A; Auricchio A; Schloss EJ; Kurita T; Sterns LD; Gerritse B; Brown ML; Fagan DH; Lexcen DR; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2877-2884. PubMed ID: 31646695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of shock energy and ventricular rhythm on the success of first shock therapy: the ALTITUDE first shock study.
    Cha YM; Hayes DL; Asirvatham SJ; Powell BD; Cesario DA; Cao M; Gilliam FR; Jones PW; Jiang S; Saxon LA
    Heart Rhythm; 2013 May; 10(5):702-8. PubMed ID: 23337541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Results of the multicenter RENEWAL 3 AVT clinical study of cardiac resynchronization defibrillator therapy in patients with paroxysmal atrial fibrillation.
    Saxon LA; Greenfield RA; Crandall BG; Nydegger CC; Orlov M; VAN Genderen R
    J Cardiovasc Electrophysiol; 2006 May; 17(5):520-5. PubMed ID: 16684026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical experience with the new detection algorithms for atrial fibrillation of a defibrillator with dual chamber sensing and pacing.
    Kühlkamp V; Dörnberger V; Mewis C; Suchalla R; Bosch RF; Seipel L
    J Cardiovasc Electrophysiol; 1999 Jul; 10(7):905-15. PubMed ID: 10413370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.